abstract |
Pharmaceutical preparation for intravenous administration, having the following, namely: a) {8-fluoro-2- [4- (3-methoxyphenyl) piperazin-1-yl] -3- [2-methoxy-5- ( trifluoromethyl) phenyl} -3,4-dihydroquinazolin-4-yl} acetic or a salt, a solvate or a solvate of a salt thereof, b) an adjuvant chosen from the cyclodextrins, and c) water. |